Heart Test Laboratories, Inc. (HSCS)

Heart Test Laboratories Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year	2023	2022	2021	2020
Cash & Equivalents	1.66	0.92	0.72	0.5
Cash & Cash Equivalents	1.66	0.92	0.72	0.5
Cash Growth	80.83%	26.92%	45.61%	-
Receivables	0	0	0	0
Inventory	0.68	0.67	0.75	0.86
Other Current Assets	0.36	0.34	0.16	0.18
Total Current Assets	2.7	1.93	1.64	1.54
Property, Plant & Equipment	0.59	0.16	0.29	0.42
Total Long-Term Assets	0.59	0.16	0.29	0.42
Total Assets	3.29	2.09	1.93	1.96
Accounts Payable	0.63	0.69	0.34	0.36
Current Debt	0.53	1.72	0.49	0.44
Other Current Liabilities	0.67	1.05	0.29	0.34
Total Current Liabilities	1.83	3.47	1.11	1.14
Long-Term Debt	1.04	4.44	2.59	0.5
Other Long-Term Liabilities	0.19	0.23	0.13	0
Total Long-Term Liabilities	1.22	4.67	2.72	0.5
Total Liabilities	3.06	8.15	3.84	1.64
Total Debt	1.57	6.16	3.08	0.94
Debt Growth	-74.59%	100.17%	226.59%	-
Retained Earnings	-60.76	-54.4	-49.57	-47.12
Shareholders' Equity	0.23	-6.06	-1.91	0.32
Net Cash / Debt	0.09	-5.24	-2.36	-0.45
Net Cash Per Share	0.01	-1.58	-0.71	-0.13
Working Capital	0.86	-1.54	0.52	0.4
Book Value Per Share	0.03	-1.82	-0.58	0.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).